USP <85> Bacterial Endotoxin Testing Services
Chromogenic LAL Method
We provide USP <85> Bacterial Endotoxin Testing (BET) services using the chromogenic Limulus Amebocyte Lysate (LAL) method for quantitative detection of endotoxins in buffers, equipment, and raw material samples.
Testing is performed using controlled laboratory procedures designed to minimize the risk of external endotoxin contamination and to ensure reliable assay performance in accordance with USP <85> Bacterial Endotoxins Test (BET) practices.
Apparatus Depyrogenation
Glassware and applicable heat-stable laboratory materials undergo depyrogenation using dry heat procedures prior to use in endotoxin testing workflows. Depyrogenation ovens are utilized to reduce or eliminate potential residual endotoxin contamination that may interfere with highly sensitive LAL assays. Careful handling procedures are implemented to help maintain endotoxin-controlled conditions during sample preparation and testing.
Water, Sample Solution, Lyste, Standard Endotoxin Stock Solution, MVD
Water for BET, sample solutions, LAL lysate reagents, and Control Standard Endotoxin (CSE) or Reference Standard Endotoxin (RSE) preparations are selected, handled, and utilized in accordance with applicable USP <85> Bacterial Endotoxins Test requirements. Water and reagents used for assay preparation are verified as suitable for endotoxin testing applications to minimize background interference and contamination risk. Sample solutions are prepared using maximum validated dilution calculations and handling procedures designed to maintain assay integrity and appropriate endotoxin recovery. LAL lysate reagents and endotoxin standards are selected, prepared, stored, and utilized according to specifications and compendial suitability criteria.
Maximum Valid Dilution (MVD) calculations are performed as appropriate to establish the greatest allowable sample dilution at which endotoxins can still be reliably detected at the specified endotoxin limit. Appropriate dilution strategies are selected based on product endotoxin limits, sample concentration, and assay sensitivity parameters.
Sample testing includes testing for interfering factors as specified by the compendial.
Only assays meeting established suitability and curve performance requirements are considered acceptable for quantitative endotoxin reporting.
What is Bacterial Endotoxins?
Bacterial endotoxins are primarily lipopolysaccharides (LPS) originating from the outer membrane of Gram-negative bacteria. When these bacteria grow, break apart, or undergo lysis, endotoxins can be released into surrounding solutions, raw materials, equipment surfaces, and manufacturing environments.
Even after bacteria are killed through sterilization processes, endotoxins may remain present because LPS molecules are highly stable and heat resistant. Unlike living microorganisms, endotoxins are not necessarily eliminated by standard sterilization alone.
Because of their biological activity, endotoxins can trigger strong inflammatory and pyrogenic responses in humans and animals, particularly when introduced through injectable products or medical devices contacting the bloodstream.
Endotoxins present unique challenges in manufacturing due to their:
- High thermal stability
- Resistance to many standard sterilization methods
- Strong surface-binding properties
- Ability to associate with proteins and biological materials
- Persistence in aqueous systems and process equipment
Certain manufacturing steps, water systems, raw materials, and handling conditions can introduce or spread endotoxin contamination if not carefully controlled.
Why USP <85> Testing is Performed
Because endotoxins may persist even in sterile materials, direct endotoxin testing is performed for verification and quality monitoring.
Routine endotoxin monitoring helps:
- Verify manufacturing cleanliness
- Assess product suitability
- Support quality control programs
- Evaluate raw materials and formulations
- Detect contamination that may not be detectable through sterility testing alone